Retail sale of pharmaceutical products
GLADSTONE AS
Operating profit
NOK −31,000
Equity
NOK 2.7m
Incorporated
2017
Share capital
NOK 30,000
Financials
Total operating revenue
Operating profit (EBIT)
Income statement
| Post | 2024 | Trend |
|---|---|---|
| Total operating costs | 31k | |
| Operating profit (EBIT) | −31k | |
| Net financial items | −335k | |
| Profit for the year | −365k |
Balance sheet
| Post | 2024 | Trend |
|---|---|---|
| Total assets | 16.4m | |
| of which current assets | 13.9m | |
| Equity | 2.7m | |
| Total liabilities | 13.6m |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.